They have the cash to cover). Things will eventually turn up. The deal with MRK long term (years) could be very profitable. There is not Epstein Barr vaccine. If that gets developed and approved, every kid going to school may have to get it as part of the protocols to enter school. During the conference call, Elias said there is the possibility during the first quarter of 2024 to enter phase 1 of clinical trials. With that comes another milestone payment. As I mentioned, this guy Elias is sharp and has been around a long time. He was part of the Sanofi management before venturing out with his team to start Modex around 10 years ago.
The charts to me show an uptrend overall. We’ll see if that holds.
News 
Market Data 
Discover 
AI
